In 2026, Firalis strategically sold its majority stake in Firalis Molecular Precision to Janvier Group Biosciences. Firalis remains a minority shareholder in the business.
Today, Firalis Molecular Precision operates as Precursion, continuing its mission to accelerate precision medicine through advanced genomics, proteomics, bioinformatics, biomarker research and biobanking.
For all CRO, bioanalytical and multi-omics activities, please visit the Precursion website.
From June 24 to 27, 2024, Amoneta‘s parent company Firalis hosted at its premises in Huningue a Summer School for the CombiDiag Doctoral Network, organized as part of the CombiDiag project.
This enlightening event, co-organized with the Rostock Medicine University (CombiDiag Coordinator), brought together Doctoral Candidates (DCs) and seasoned professors for a series of insightful and engaging activities.
The summer school provided an exceptional opportunity for CombiDiag’s DCs to present their thesis projects and latest advances in their research.
Candidates received valuable feedback and insights from professors, which helped to refine and enhance their research directions. The exchange of ideas and constructive criticism created an atmosphere fostering growth and innovation.
Participants also benefited from lectures delivered by field experts on peripheral biomarkers and their combinatorial use in diagnosing early-stage Alzheimer’s disease. These sessions offered in-depth knowledge and cutting-edge advancements in the field, equipping the DCs with a comprehensive understanding of the latest research trends and methodologies.
Beyond the academic discussions, the Summer School included a tour of the Firalis premises, allowing DCs to gain a deeper understanding of the company’s activities, technological capabilities, and ongoing projects.
The Summer School also featured various team-building activities.
The Summer School for the CombiDiag Doctoral Network was a resounding success, providing a perfect blend of academic rigor and fun. The event reinforced the importance of interdisciplinary research and cooperation in advancing the field of Alzheimer’s disease diagnosis.
Originally published by Amoneta Diagnostics on 2 July 2024.